Nexium (Esomeprazole Magnesium Trihydrate)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral formulation for oral use. It treats gastro‑oesophageal reflux disease and related acid‑related conditions in adults.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and heals esophageal irritation. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - NSAID‑induced gastric ulcer: protects the gastric lining and supports ulcer healing. - Helicobacter pylori eradication (in combination): enhances the effectiveness of antibiotic regimens by lowering gastric acidity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: abnormal liver function tests. - Bone fracture risk: increased susceptibility with long‑term use.

Before initiating therapy, consider the following precautions. - Renal function assessment: adjust use in severe renal impairment. - Hepatic impairment: monitor liver function in patients with liver disease. - Magnesium monitoring: check serum magnesium during prolonged treatment. - Long‑term use evaluation: reassess necessity after several months. - Drug‑specific contraindications: avoid in known hypersensitivity to esomeprazole. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Esomeprazole may alter the plasma concentrations of several co‑administered drugs. Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet activity. Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Methotrexate: potential accumulation. - Phenytoin: altered anticonvulsant concentrations.